New Mouse Model for Treating Pediatric Brain Tumors
Author Information
Author(s): Seblani Maggie, Zannikou Markella, Duffy Joseph, Levine Rebecca, Thakur Aditi, Vallcorba Montserrat Puigdelloses-Horbinski Crag, Miska Jason, Hambardzumyan Dolores, Becher Oren, Balyasnikova Irina
Hypothesis
Can a genetically engineered mouse model effectively study and target pediatric high-grade gliomas with CAR T cells?
Conclusion
The new mouse model allows for effective evaluation of CAR T-cell therapies, significantly extending survival in treated mice.
Supporting Evidence
- The model developed allows for the study of pediatric high-grade gliomas and pediatric diffuse midline gliomas.
- Tumors in the model exhibited aggressive characteristics and typical features of high-grade glioma.
- CAR T-cell treatment in the model significantly extended survival compared to control.
Takeaway
Researchers created a special mouse to help test new treatments for kids with brain tumors, and it worked really well!
Methodology
Developed a genetically engineered mouse model incorporating IL13RA2 and induced gliomagenesis using the RCAS-Tva system.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website